VPS: The Vancomycin Piperacillin/​Tazobactam (VPT) Patient Safety Trial

The VPT Safety Trial (VPS) compares two common antibiotic combinations to see how they affect the kidneys of patients in the hospital with serious infections. The antibiotics in the two combinations are approved by the Food and Drug Administration (FDA). The goal is to help doctors know which combination is safer so they can make better choices for their patients.

ClinicalTrials.gov Identifier: NCT07556107

See the participating clinical sites on the map below. For site details, visit ClinicalTrials.gov